Liu et al. identified Metallothionein 2A (MT2A) as the target of the miR-23a in gastric cancer and MT2A suppression may mediate the promoting effect of miR-23a on the gastric cancer progression [76]. This evidence concerns the gene MT2A and gastric cancer.